Bioverativ

Bioverativ

Bioverativ

Twitter channel for Bioverativ, a global biotechnology company focused on hemophilia and rare blood disorders. Community guidelines on our site
Type
B2b
Founded
2017
Follow us
Alexa global traffic share
Twitter followers
Team Size
200+
Employees
$400,000,000
Xconomy

Not Resting on Hemophilia Biz, Bioverativ Pays $400M For True North

Health Strategy
Xconomy

Better Together, or Apart? Biogen, Bioverativ Head Down Separate Paths

Health Strategy Stock markets